Image

Virtual Nephrologist

Virtual Nephrologist

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

To develop, pilot, and refine a virtual healthcare agent that will educate patients with advanced chronic kidney disease and their caregivers about kidney transplantation.

Description

Over 35 million Americans endure the burdens of chronic kidney disease (CKD). Black Americans face particularly high rates of CKD due to environmental and genetic factors, including systemic racism and inadequate access to specialty providers and effective therapies. The optimal management of advanced CKD poses many challenges for patients, especially those with low health literacy, because of the complexity of medical management and treatment options. For many patients with advanced CKD, pursuing kidney transplantation has major advantages. Compared to chronic dialysis, kidney transplantation improves quality of life and length of life, and offers greater capacity to participate in important activities such as employment. Unfortunately, many patients do not gain sufficient information about kidney transplant or have misconceptions and fears about transplant. This knowledge gap exists in part because many patients have limited access to nephrology care and due to time constraints and ineffective education during nephrology visits. New media technologies can address this need by enabling patients to interact with a virtual health care assistant that both empowers patients to direct the communication toward their own information needs and communicates with patients using language and norms that are comfortable. The study team will develop a virtual healthcare assistant to interact with, educate and counsel patients and their caregivers about kidney transplantation. The tool will provide content developed by the National Kidney Foundation, the leading patient-facing organization focused on kidney disease. Informed by patient partnerships, the tool will address in particular the needs and concerns of Black Americans with kidney disease.

Eligibility

Inclusion Criteria:

  • 18 y/o able to provide consent
  • Advanced CKD
  • English speaking
  • Penn Medicine patient

Exclusion Criteria:

  • Vulnerable populations

Study details
    Chronic Kidney Disease(CKD)

NCT06841016

University of Pennsylvania

17 September 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.